🎬 Jana Nayagan hits 305 crore worldwide

Thalapathy Vijay's film, Jana Nayagan, has crossed the 300-crore mark at the worldwide box office. The movie is currently in theaters in Kollywood, having grossed 306.24 crore over 13 days. On the 13th day, it added 3.23 crore, showing a slight drop from the previous day's earnings. The film needs just 8.77 crore more to surpass Suriya's Karuppu, which is currently at 315 crore. If it achieves this, Jana Nayagan will enter the top 10 highest-grossing Tamil films globally. 🎬

🇨🇦 Canada's Express Entry pool shrinks despite score bumps

The Express Entry pool contracted by over 2,400 profiles between July 19 and August 3, even with a surge of more than 1,500 candidates in the 501–600 CRS score range. This drop occurred across most lower CRS ranges, while growth was seen above that threshold, except for the highest band. Four selection rounds between July 19 and August 3 issued 7,515 invitations. The August 3 data snapshot does not include invitations from the August 4 and August 5 draws. 🇨🇦

🎬 Lokesh Kanagaraj's DC debut: safe zone targets

Lokesh Kanagaraj is making his acting debut in the crime-action thriller DC, which releases this Friday, August 7th. The film is set to star him alongside Sanjana Krishnamoorthy and Avinash Raghudevan. It was reportedly made on a controlled budget of 25 crore, with director Arun Matheshwaran and Anirudh reducing their fees. To enter the safe zone, DC needs to gross 25 crore net at the Indian box office. A clean hit status would require the movie to reach a net collection of 50 crore. 🎬

🌟 Can Kiara's 'Toxic' beat War 2 for a record opening?

Kiara Advani is set to release her highly anticipated film, Toxic-A Fairytale For Grown-Ups, directed by Geetu Mohandas. The movie features Yash, Nayanthara, and Huma Qureshi, with a grand opening planned for August 26th. To become her biggest opener, the film must surpass War 2's opening day net collection of 52.5 crore. This is crucial as her previous big films, Game Changer and War 2, faced box office struggles. The film's trailer is dropping on August 8th, keeping the buzz high. 🎬

🎬 India key for Netflix's global growth, says Ted Sarandos

Ted Sarandos stated that India is central to Netflix's next growth phase due to its huge appetite for entertainment. The co-CEO noted that India has 20-25 million paid users out of a 325 million global base. Netflix learned that audiences are value-conscious and require consistent, varied content across all genres. While they won't bid for full IPL rights, they focus on unique, eventisable live sports moments. Ultimately, success in India means balancing revenue with significant cultural impact. 🤩

🚀 Can Sunny Deol match Ranveer Singh's profit streak?

Ranveer Singh currently holds the record as the only actor with two films netting over 300 crore in profit. Sunny Deol is eyeing this spot with his upcoming movie, Batwara 1947. His previous hit, Gadar 2 in 2023, secured him one entry into this club with a 450.50 crore net profit. Now, the performance of Batwara 1947, directed by Rajkumar Santoshi and produced by Aamir Khan, is crucial. If it hits 300 crore profit, Deol will become the second actor to achieve this milestone. 💰

🔬 New genetics point to fibromyalgia as brain disorder

New research in Nature Medicine suggests fibromyalgia is fundamentally a central nervous system disorder. The study was a meta-analysis across 2,563,755 individuals, identifying 26 risk loci linked to brain and neural genes. This provides strong evidence supporting a neural disease model over an autoimmune one. Genetic overlap was found with conditions like PTSD and IBS, suggesting shared pathways. Future treatments might utilize targeted brain stimulation based on these gene findings. 🧠

🎬 Ajay Devgn aims for historic 300 crore with Drishyam 3

Ajay Devgn is aiming to script history with the upcoming film Drishyam 3. The movie is expected to be a major hit for him in the Indian box office. Drishyam 2 grossed a solid 241 crore net, leading to a minimum target of 300 crore net for the threequel. This film could become the first Indian threequel to hit the 300-crore net mark in India. Drishyam 3 is scheduled for release on Gandhi Jayanti, October 2, 2026. 🎬

🌬️ Benralizumab cuts mucus in severe asthma patients

Treatment with benralizumab significantly lowered the overall mucus burden in patients suffering from severe eosinophilic asthma. The multicenter phase 4 study took place between October 2022 and July 2024 involving 39 patients across various sites. Mucus volume dropped by 61% from a mean of 0.21 mL to 0.08 mL at week 13. This reduction correlated with better breathing function, while safety remained favorable with no reported deaths. These results support previous findings on improving asthma control in poorly managed eosinophilic asthma. 🌬️

🛡️ Taiwan starts war games drills

Taiwan has initiated a series of war games to enhance its national defense capabilities. These exercises are being conducted across various military bases within Taiwan. The drills commenced on a specified date, with participation from multiple armed forces units. The purpose of these exercises is to prepare for potential regional conflicts and bolster readiness. Further details regarding the scale and outcomes of these games are expected in the coming weeks. 🛡️

👃 Sinus surgery helps life quality for polyp patients

Both full and limited Functional Endoscopic Sinus Surgery (FESS) significantly boosted quality of life for patients with chronic rhinosinusitis and nasal polyps. The study, conducted at two Finnish university hospitals, included 97 patients aged around 47 years. Results showed significant reductions in HRQOL scores at 12 and 24 months post-surgery for both groups. While full FESS showed better short-term results for anosmia and polyp scores, both approaches reduced oral corticosteroid use. Doctors suggest limited FESS is useful for cases where general anesthesia is risky.